Navigation Links
Pfizer Invites Public to View and Listen to Webcast of November 2 Conference Call With Analysts
Date:10/4/2010

NEW YORK, Oct. 4 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 2, 2010. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's Third Quarter 2010 Performance Report, to be issued that morning.

(Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO)

To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com and click on the "Pfizer Quarterly Corporate Performance – Third Quarter 2010" link in the Investor Presentations section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today.  Participants are advised to pre-register in advance of the conference call.  

You can also listen to the conference call by dialing either 866-246-2545 in the United States and Canada or 706-634-2365 outside of the United States and Canada. The password is "Third Quarter Earnings".

Visitors to www.pfizer.com will be able to view and listen to an archived copy of the webcast of the conference call.


'/>"/>
SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer
2. Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
3. Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
4. Amgen and Pfizer Introduce Psophisticated Style: A Guide to Everyday Style and Psoriasis™ Hosted by Tim Gunn
5. Pfizer to Acquire FoldRx Pharmaceuticals
6. World Health Organization Grants Prequalification to Prevenar 13*, Pfizers 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children
7. Conatus Pharmaceuticals Acquires Pfizers Idun Subsidiary
8. Pfizer Suspends Chronic Pain Studies in Tanezumab Clinical Trial Program; Some Studies Continue in Areas of Unmet Medical Need
9. Pfizer and SMC Collaborate on Liver Cancer
10. Pfizer to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at Alzheimers Association International Conference on Alzheimers Disease
11. Pfizer Inc and GoIndustry DoveBid Partner to Auction Surplus Equipment from R&D Facilities Across the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 According ... Product (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, ... & Indication (AF, VT, WPW) - Global Forecasts to ... expected to reach around ~$4.73 Billion by 2019 with ... 2014 to 2019. Browse   90 ...
(Date:3/27/2015)... , March 27, 2015  RXi Pharmaceuticals ... MirImmune LLC, today announced that they have ... RXi,s novel and proprietary sd-rxRNA® technology for ... The collaboration has the potential to result ... cancer treatments that could be a significant ...
(Date:3/27/2015)... -- Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator ... imaging centers in China , ... under which Concord Medical Services (International) Pte Ltd, ... to acquire the Fortis Surgical Hospital from Fortis ...
Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3
... ClinOps, LLC, a customer service focused clinical research ... the company as Senior Vice President of Clinical ... 28 years of clinical research experience in multiple ... central nervous system, oncology, etc. , In her ...
... ORANGE COUNTY, Calif., Oct. 26 Beckman Coulter, Inc. (NYSE: ... products that simplify, automate, and innovate complex biomedical testing, announced ... , Oppenheimer & Co. Healthcare Conference - Wednesday, November ... Conference - Friday, November 13, 2009 at 11:00 a.m. ET ...
Cached Medicine Technology:ClinOps, LLC Enhances Senior Management Team With Addition of Connie Andrews as Senior Vice President of Clinical Operations 2
(Date:3/28/2015)... York, NY (PRWEB) March 28, 2015 ... that offers urgent care in Manhattan, recently commemorated its ... care facility in Manhattan. In addition to 24-hour urgent ... ER facilities. , At this time, Emergency Medical ... for abdominal pain, asthma, chest pain, eye injuries, ear ...
(Date:3/28/2015)... March 28, 2015 An article in ... which could prove critical to organizations that deal with ... critical aspect of data security, is worsening . ... security report, every major category out of the twelve ... testing. “With all the craziness that has gone on ...
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple ... injuries, according to new research released today at the American ... , “Our findings indicate that a 10 inch increase in ... a history of injury, a 10 mile per hour increase ... a history of injury, and playing for more than one ...
(Date:3/28/2015)... How best to treat and recover ... orthopaedic medicine. While diagnostic hip injections are commonly performed ... etiology, research presented today at the American Orthopaedic Society ... that pain relief from this diagnostic injection may not ... “Our study looked to assess if the amount of ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Early surgery ... with Type V AC joint injuries, according to new ... today at the American Orthopaedic Society for Sports Medicine’s ... to duty faster when surgery was not performed. , ... 7 receiving surgical treatment and 17 receiving non-surgical therapy. ...
Breaking Medicine News(10 mins):Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2
... have the largest volume of surgical procedures does not necessarily ... the results of a new study in the February issue ... . The findings of studies that suggest the higher ... hospital, the better that hospital,s outcomes will be, has resulted ...
... diseases like Alzheimer,s and Parkinson,s are partly attributable to ... Institutet in Sweden now demonstrate in a paper published ... enzymes can prevent the inflammation and thus constitute a ... microglial cells the nerve system,s primary immune cells ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, March ... diabetes were able to get injections of a new insulin drug ... findings still need to be confirmed in another phase of research, ... it were approved for this use. But those caveats aside, ...
... colleagues at Case Western Reserve University School of Medicine have ... a universally fatal, degenerative brain disease for which there is ... and typically leads to death within a year of disease ... of PLoS ONE, a scientific journal produced by ...
... HealthDay Reporter , WEDNESDAY, March 9 (HealthDay News) ... kids, brains are developing an ability to help fight ... Over a three-year period, researchers from Oregon and California studied ... insight into the brain,s wiring during adolescence, finding the most ...
... WEDNESDAY, March 9 (HealthDay News) -- Stroke survivors recover ... involved in their exercise therapy, a new European study ... stroke survivors found that adding family-assisted exercise therapy to ... distance walked, and ability to perform activities of daily ...
Cached Medicine News:Health News:Referral to high-volume hospitals for operations fails to improve outcomes statewide 2Health News:New Drug May Trim Insulin Injections to Just 3 a Week 2Health News:Researchers identify new biomarker for Creutzfeldt-Jakob disease, the human form of mad cow disease 2Health News:Researchers identify new biomarker for Creutzfeldt-Jakob disease, the human form of mad cow disease 3Health News:As Peer Pressure Increases, So Does Brain's Ability to Resist It 2Health News:As Peer Pressure Increases, So Does Brain's Ability to Resist It 3Health News:Family Involvement Helps Stroke Patients With Rehab 2
The Acceava hCG Combo test provides superior performance for the diagnosis of pregnancy with a simple procedure that provides easy to read black on white results in 3 minutes for urine or 5 minutes f...
The Acceava pregnancy urine dipstick test provides qualitative determination of human chorionic gonadatropin in urine for early detection of pregnancy....
... Nucleic Sample Preparation Platform provides flexible, automated ... platform can prepare up to 96 patient ... and one half-hours, and performs onboard quantitation ... 30 minutes each. Based on Beckman ...
The Acceava Trichomonas Rapid Test is an immunochromatographic assay that detects pathogen antigens directly from vaginal swabs. Results are rapid, occurring within approximately 10 minutes....
Medicine Products: